Abstract: The present invention relates to control of a wind turbine to reduce structural loading due to vibrations of the blades along the edgewise direction. A rotor control system for actuating pitch of pitch-adjustable rotor blades of a wind turbine is disclosed. Pitch modification signals are determined based on edgewise load signals for each of the rotor blades. The edgewise load signal are coordinated transformed and input into a primary whirling controller unit to provide whirling signal components which can be used for determining the pitch modification signals.

Abstract: A system and method for presenting three-dimensional content that can present the three-dimensional content with a fidelity that can be matched to a fidelity or perceivable depth achievable by the display. The system or method can include receiving content, converting the content to a shared representation that can be used for any display, displaying the content on the display via the shared representation.

Abstract: A method or system can be configured to receive content associated with a scene; optionally, format the content as a three-dimensional image; render the content or three-dimensional image in a display-readable format; optionally, authenticate the display; and display the formatted content such that the formatted content is perceivable as three-dimensional for one or more viewers.

Abstract: A method or system can be configured to receive content associated with a scene; optionally, format the content as a three-dimensional image; render the content or three-dimensional image in a display-readable format; optionally, authenticate the display; and display the formatted content such that the formatted content is perceivable as three-dimensional for one or more viewers.

Abstract: A ship's radiated noise monitoring system includes a plurality of arrays of spaced vibration-responsive detectors, the arrays being adapted for location adjacent to the ship's hull in the region of possible noise sources; summing amplifiers for receiving the detectors output signals from respective arrays and providing output signals representative of the average vibration signals received by each array; an analyzer connected to the output of each summing amplifier to perform a spectrum analysis; and computer apparatus to receive the noise spectrum from each array, apply respective weighting factors to the noise spectra and combine the weighted noise spectra to produce a predicted radiated noise spectrum. Preferably each array comprises a regular distritution of nine accelerometers attached to hull frames in groups of three. The system is used in conjunction with sonar equipment to enable self-noise to be monitored to optimise the sonar performance.

Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.

Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.

Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).

Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).

Abstract: The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGF?), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGF?1, TGF?2 and TGF?3, so-called “pan-specific” antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).

Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.

Abstract: A fabricated panel structure such as a boat hull includes a plurality of elongate flexible cores 10 of a low strength foam material which are each individually covered by a respective strip 20 of fibrous material wrapped around each core in a spiral fashion. The covered members are arranged side-by-side sandwiched between inner and outer layers 24 and 26 of fibre-reinforced plastics material which are bonded to the cores.

Abstract: The invention provides a one-stage method of measuring antithrombin (AT) activity in a sample. In the method, a diluted sample is mixed with AT-deficient plasma containing intrinsic coagulation enzymes, an AT augmenting compound such as heparin, a phospholipid and an activator of the contact phase of the intrinsic coagulation pathway. Following addition of calcium ions, coagulation time is measured and compared to a reference standard to determine the level of AT activity in the sample.

Abstract: A method is described for electronically recording messages after the called telephone goes off-hook. The method may be physically implemented by an apparatus in the home or office, or by a system installed in a service provider central office. When a call is received, the telephone receiver is taken off the hook and the caller is asked if they would like to leave an electronic message. If the caller decides to leave an electronic message, the record function is initiated by the answering party via a record button physically provided on the system, by a keystroke sequence on the telephone station set keypad, or by voice command. The message speech is sampled, each sample is processed to extract speech information, each extracted signal is encoded, and then each encoded signal is stored in memory.

Abstract: A method and system for automatically performing one or more operations on multiple computer systems within a cluster are disclosed. In accordance with the present invention, a begin operations command construct is defined within an input file. In addition, an input command indicating one or more operations to be performed on at least two computer systems within the cluster and an end operations command construct are defined. In response to a selected input, one or more operations indicated by the input command are automatically performed on at least two computer systems. In accordance with one embodiment, the begin operations command construct indicates selected computer systems within the cluster on which the one or more operations are to be performed and whether the operations are to be performed on the selected computer systems serially or in parallel.

Abstract: In accordance with the present invention, a method is provided for treating tumors. More particularly, the present invention relates to a method for treating tumors comprising injecting a solution of certain ethylene oxide-propylene oxide surface-active copolymers and a solution containing chemotherapeutic agents into a human or animal with a tumor. The solutions can be injected simultaneously or separately at different times. In addition, the surface-active copolymer and the chemotherapeutic agent can be in the same solution. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula:HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (O.sub.2 H.sub.4 O).sub.b Hwherein a is an integer such that the hydrophobe represented by (C.sub.3 H.sub.6 O) has a molecular weight of approximately 950 to 4000 daltons, preferably approximately 1200 to 3500 daltons, and b is an integer such that the hydrophile portion represented by (C.sub.2 H.sub.

Abstract: A bag is disclosed for the collection, freezing, storage, and rapid thawing of fluids, and particularly blood and blood components. Front and back sheets of fluid impervious material are bonded to one another along edge portions thereof to form a bag defining a reservoir. The front and back sheets are further bonded together at a plurality of locations intermediate the edge portions to constrain the distance by which the front and back sheets can separate. The intermediate fastening locations are disposed to permit uniform filling of the reservoir. A port is provided for introducing and discharging fluid into and out of the reservoir. When a fluid is introduced into the reservoir, the front and back sheets are constrained from separating in response to a pressure exerted by the fluid by the intermediate fastenings between the front and back sheets to constrain the thickness of the bag.

Abstract: The temperature of bags of blood or blood components is varied by directing a heated or refrigerated flow of air through vents (138) of pairs of opposing ducts (130A, 130B) longitudinally spaced across gaps to present thermal processing chambers (136) into which the bags are received. The vents are centrally located on vertical tubes (132) laterally separated by vertical air return slots (135), and act to direct the airflow substantially perpendicular and with turbulence against the bags. In a described thermal processing unit (110), the spacings of the vents and tubes are chosen to match the corresponding spacing of vertical tubular chambers (62) of a preferred bag (10) with which the unit (110) can be used.

Abstract: In accordance with the present invention, a composition and method is provided for perfusion of organs. The present invention includes perfusion of organs in situ and before transplantation. The method comprises perfusing an organ with a perfusion medium containing an effective amount of a surface active copolymer. The surface active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula:HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b Hwherein a is an integer such that the hydrophobe represented by (C.sub.3 H.sub.6 O) has a molecular weight of approximately 950 to 4000, preferably approximately 1200 to 3500, and b is an integer such that the hydrophile portion represented by (C.sub.2 H.sub.4 O) constitutes approximately 50% to 90% by weight of the compound.

Abstract: In accordance with the present invention, a method is provided for improving angioplasty procedures by reducing tissue damage during the procedure comprising infusing a non-emulsion, homogeneous solution of certain ethylene oxide-propylene oxide surface-active copolymers before, during and/or after the angioplasty procedure. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula:HO(C.sub.2 H.sub.4 O).sub.b (C.sub.3 H.sub.6 O).sub.a (C.sub.2 H.sub.4 O).sub.b Hwherein a is an integer such that the hydrophobe represented by (C.sub.3 H.sub.6 O) has a molecular weight of approximately 950 to 4000 daltons, preferably approximately 1200 to 3500 daltons, and b is an integer such that the hydrophile portion represented by (C.sub.2 H.sub.4 O) constitutes approximately 50% to 90% by weight of the compound.